Form 4 for STAA STAAR SURGICAL CO
Accepted 2026-06-22 16:05:08 ET · period of report 2026-06-18 · accession 0001678249-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-22 16:05 | 2026-06-18 | STAA | Butcher Arthur C | Dir | M - OptEx | $0.00 | +5,341 | 9,549 | +127% | $0 |
| D | 2026-06-22 16:05 | 2026-06-18 | STAA | Butcher Arthur C | Dir | M - OptEx | $0.00 | -5,341 | 0 | -100% | $0 |
| DM | 2026-06-22 16:05 | 2026-06-18 | STAA | Butcher Arthur C | Dir | A - Grant | $0.00 | +8,167 | 3,709 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-18 | M | A | 5,341 | $0.00 | 9,549 | D | — | — | (F1) Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. |
| 2 | Derivative | Restricted Stock Units | 2026-06-18 | M | D | 5,341 | $0.00 | 0 | D | $0.00 · — to — | 5,341 Common Stock | (F1) Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. (F1) Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. (F1) Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. |
| 3 | Derivative | Common Stock Options | 2026-06-18 | A | A | 4,458 | $0.00 | 4,458 | D | $29.12 · 2027-06-18 to 2036-06-17 | 4,458 Common Stock | (F2) Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. |
| 4 | Derivative | Restricted Stock Units | 2026-06-18 | A | A | 3,709 | $0.00 | 3,709 | D | $0.00 · — to — | 3,709 Common Stock | (F2) Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. (F2) Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. (F2) Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. |